Fenergo: Global OTC Derivative Reform In APAC

Global OTC derivative reform is challenging financial institutions across the world to rethink their abilities to achieve compliance in an efficient and coherent manner.

In this paper, Charles Carter-Richards from FinReg and Andy Mantzios from Fenergo outline the enormity of the challenge facing financial institutions striving to comply with a patchwork of OTC derivative regulatory rules within tight regulatory schedules and with little harmonisation between regulatory regimes.

The authors

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a RiskTech Forum account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: